Quick Intro — Who You Are & What’s Urgent

• Tell us your name, role, company, and the product or program you're exploring manufacturing for.
• Which best describes your organization? Options: National grocery retailer (private label), Emerging CPG brand, Established CPG/brand, Foodservice distributor/chain, Co-manufacturer/other
• What triggered this conversation today—new product launch, co-manufacturer failure, audit issue, capacity shortfall, or something else? Options: New product launch, Recall or quality failure, Failed or upcoming audit, Capacity constraint / peak season, Packaging or regulatory hold, Other
• How urgent is resolution on this (open planning, 1–3 months, 3–6 months, immediate/within weeks)? Options: Open planning (>6 months), 3–6 months, 1–3 months, Immediate (within weeks)
• Is there a retailer or channel deadline we should be aware of (seasonal drop, promotional window, audit date)? If so, when?

If One Bad Batch Could End Your Brand, What’s at Stake?

• Imagine a public recall under your label—what would that do to revenues, retailer relationships, and internal morale over the next 90 days?
• Which of these have you experienced in the last 24 months? Options: Retailer warning or suspension, Product recall, Failed SQF/BRC audit, Chronic late deliveries, Significant sensory complaints, None of the above
• When quality or delivery problems happened, how did your customers respond (chargebacks, delist, extra audits, stepped-up testing)? Options: Chargebacks/penalties, Delist or canceled orders, Additional retailer audits, Increased sampling/testing, Escalation to executive/supply chain, Other
• Who inside your organization bears the most pain when these events occur—who gets woken up at 2 a.m.? Options: Brand Manager, Supply Chain Director, Procurement, QA/Regulatory, Legal, Commercial/Retail Ops
• How long has this level of supply risk or quality concern existed for your program? Options: This is new (within 3 months), Short-term (3–12 months), Longstanding (1–3 years), Persistent for many years

Where Your Current Production Actually Breaks

• What’s the single recurring production problem you wish would stop tomorrow?
• Describe the top capacity constraints you face (line speed, run-size minimums, packaging availability, seasonal peaks).
• Which parts of production have the most recent quality failures: formulation, cooking/baking, fill/seal, packaging, cold chain, or labeling? Options: Formulation/scale-up, Cooking/baking process, Fill / seal / packing, Packaging integrity, Cold-chain handling, Label/regulatory errors, Other
• Which suppliers or upstream inputs are the most fragile for your product? Options: Specialty ingredients, Co-manufacturer partners, Primary packaging, Secondary packaging/retail-ready packs, Cold-storage carriers, Other
• How predictable are your current lead times for finished goods (including packaging and specialty ingredients)? Options: Very predictable (±5%), Mostly predictable (±10–20%), Unpredictable (>20%), Highly volatile/unreliable
• When a quality issue arises, what is your typical escalation path and timeline from detection to decision (who's involved and how long does it take)?

The Audit & Acceptance Bar — How Close Is Close Enough?

• If we met your audit requirements on paper but a trial-batch sensory panel flagged a critical flavor difference, would you accept remediation or pause the launch? Options: Accept with remediation plan, Pause until sensory match, Require new formulation work, Depends on retailer tolerance
• What audit level or score do your retailers or foodservice customers require (SQF/BRC thresholds, score minimums, or specific clauses)? Options: SQF Level 3 or equivalent, SQF Level 2 acceptable, BRC A/AA required, Retailer-specific audit only, No formal requirement
• Which sensory attributes are absolute non-negotiables (select all that apply)? Options: Taste/profile match, Texture/mouthfeel, Aroma, Appearance/color, Melt/aftertaste, Packaging/performance
• What numeric or measurable acceptance thresholds do you use for trial batches (acceptable defect %, sensory score threshold, microbiology limits)? Please give examples.
• How important are references from existing customers in your evaluation—how many references would be persuasive and of what type? Options: Critical (3+ similar customers), Important (1–2 similar customers), Nice-to-have, Not necessary
• Do you require on-site audits and supplier access, or is remote documentation review acceptable for initial qualification? Options: On-site audits mandatory, Remote review acceptable initially, Hybrid: remote then on-site before production, Depends on retailer/client

Who Holds the Keys — Decision Roles, Approval Gates & Timelines

• If a partner could guarantee capacity but was 5% higher cost, would your team prioritize speed or price? Options: Prioritize speed/capacity, Prioritize lower cost, Balance equally, Depends on product/channel
• List the stakeholders and approval gates required to select a manufacturing partner (role, typical sign-off authority, and contact if available).
• Who has final legal or commercial sign-off (Procurement, Legal, Brand, Supply Chain, Retailer)? Options: Procurement, Legal, Brand/Marketing, Supply Chain/Operations, Retailer/Category
• What are the non-negotiable calendar dates (retailer drop, promo start, peak season) that constrain your launch?
• How long does your typical internal approval cycle take—from vendor short-list to PO (weeks)? Options: <2 weeks, 2–4 weeks, 1–3 months, >3 months
• Who will be the primary day-to-day contact for production planning and issue escalation on your side?

Hidden Constraints & Non‑Negotiables You Haven’t Said

• What constraint would make you walk away even if price, audit level, and capacity were perfect?
• Do you have strict ingredient sourcing rules (approved vendor list, organic/GMO-free, country-of-origin restrictions)? Options: Approved vendor list only, Require organic/non-GMO, Country-of-origin restrictions, No special sourcing rules, Other
• Do you need IP or formulation protections (NDAs, escrow of formulas, restrictions on future customers)? If yes, what level? Options: Standard NDA, Detailed IP clause required, Formula escrow/third-party custodian, Must not manufacture for competitors, No special protections
• Are there packaging, sustainability, or retailer spec constraints (recyclable materials, barcode/retail-ready specs, shelf-ready trays) we must meet? Options: Retailer dieline/spec required, Recyclable/eco material required, Shelf-ready retail pack required, Special labeling/claims restrictions, None
• Describe any regulatory or label approval workflows we should plan for (who reviews, average lead time, regulatory body).

What Success Looks Like — Metrics, Feelings, and Worst‑Case Escapes

• If this launch is a poster child for success, what three outcomes would your leadership highlight?
• What are the top measurable launch targets (cases/month, fill rate %, on-time delivery %, first-pass yield)? Please list values.
• Which customer-facing KPIs matter most (customer complaints per 10k units, shelf-life weeks, visual defects %)? Options: Complaints per 10k units, Shelf-life in weeks, Visual/package defects %, On-shelf availability, Other
• At what exact threshold would you trigger a rollback, safety hold, or invoking of an escape clause?
• How much operational visibility do you need post-launch (daily dashboards, weekly QA reports, on-site audits)? Options: Daily dashboards + weekly QA, Weekly reports, Monthly summaries, On-demand access only

Early Signals & Practical Next Steps — What Would Make This Easy?

• What's the one small demonstration or deliverable that would make you say 'let’s move forward' today (sample pass, audit report, capacity hold)?
• Which trial-batch outcomes would immediately satisfy you (sensory panel pass, lab results, packaging integrity, retailer sign-off)? Options: Sensory match to spec, Micro results within limits, Packaging/closure integrity, Retailer acceptance sample, All of the above
• What is your preferred timeline for running an initial trial batch and who must approve the release of samples? Options: Within 2 weeks, 2–4 weeks, 1–2 months, Longer than 2 months
• Do you have specialty ingredients or packaging with long lead times we should reserve now? If so, list them and typical procurement lead times.
• How many supplier references or factory visits would you want before finalizing (and would remote audits be acceptable)? Options: 3+ in-category references, 1–2 references, Factory visit required, Remote audits acceptable, Other
• What documentation would speed internal approval (SOPs, SQF/BRC audit reports, insurance certificates, COAs)? Options: SOPs/process docs, Recent SQF/BRC audit report, Insurance and liability docs, COAs for ingredients, Supply agreements/capacity guarantees

Tell Us About Your Current Program — Start Where It Feels Easiest

• Which of the following best describes why you've asked us to look at your production landscape right now? Options: New product launch (need external capacity), Emergency re-source after quality failure/recall, Scale-up from pilot to full production, Supplier consolidation/diversification, Exploratory — assessing co-manufacturing options, Other
• Which product categories are in scope for this initiative? Options: Snacks, Baked goods, Sauces & dressings, Seasonings & mixes, Frozen prepared foods, Other
• What are the target launch volumes and cadence (cases/month or units/week)?
• What is your ideal go-live window or critical deadline? Options: Within 30 days, 30–60 days, 2–3 months, 3–6 months, Unsure
• Who are the primary internal stakeholders we should know about (roles and decision timelines)?
• What keeps you up at night about handing this program to an external manufacturer?

If We Look Closely, What’s Actually Holding You Back?

• What hidden production constraints are quietly dictating your options — not budget or specs, but the real bottlenecks?
• Which of the following constraints have affected your runs in the last 12 months? Options: Line changeover time, Minimum run-size limits, Packaging format limitations, Allergen line separation, Equipment speed or capacity, Sanitation window limitations, Other
• How predictable is your current line availability on a weekly basis? Options: Highly predictable (95%+ on-schedule), Mostly predictable (80–95%), Variable (60–80%), Unreliable (<60%), Don't know
• Tell us about a recent production constraint that forced a change in plan—what happened and who made the call?
• How long are typical equipment changeovers for the product(s) in scope (hours)? Options: <1 hour, 1–2 hours, 2–6 hours, 6–12 hours, 12+ hours, Unknown
• What would 'acceptable' manufacturing flexibility look like to you (e.g., run-size, lead time, lane-sharing)?

When Quality Cracks, Who Feels the Heat — and How Bad Is It?

• Think back to the most recent quality incident—what was the first sign that something was wrong, and who noticed it?
• In the last 24 months, which of these quality events have you experienced? Options: Recall, Retailer chargebacks, Failed SQF/BRC audit, Customer returns for off-spec, Regulatory warning, None of the above, Other
• What measurable impacts did that event have (select all that apply)? Options: Units scrapped, Revenue lost, Retail delist/penalty, Shelf hold/withdrawal, Brand reputation damage, Operational downtime, Other
• How quickly was the root cause identified and by whom (hours/days)? Options: <24 hours, 1–3 days, 4–7 days, More than a week, Root cause not determined
• What corrective actions were effective, and which failed to prevent recurrence?
• How would you describe your tolerance for quality variance on sensory attributes (taste/texture/appearance) during scale-up? Options: Very low — must match pilot exactly, Moderate — small variance acceptable, High — some adjustments expected, Unsure

Your Suppliers — Trusted Partners or Surprises Waiting to Happen?

• How often do suppliers force you to change specs, lead times, or ingredients at short notice? Options: Frequently (monthly), Sometimes (quarterly), Rarely (annually), Never, Don't know
• Which ingredients or packaging components are single-sourced or have no approved alternate today?
• What supplier controls do you currently rely on (select all that apply)? Options: Approved vendor list, Certificate of analysis (COA) requirement, Supplier audits, Long-term contracts, Safety stock agreements, None of the above, Other
• Tell us about a supplier disruption that forced a product change or delay—what contingency (if any) was available?
• How confident are you in the traceability and COA documentation you currently receive from your key suppliers? Options: Very confident, Somewhat confident, Not confident, Don't know
• Would you be willing to share supplier audit reports or COAs with a prospective co-manufacturer under NDA to speed qualification? Options: Yes, Maybe — requires NDA, No

Who Moves When Things Go Sideways — Real Escalation, or Just More Meetings?

• When a critical quality or supply issue arises, what is the first three-step sequence that gets triggered?
• Do you have a documented escalation matrix and RACI that covers recalls, audit failures, and supplier stoppages? Options: Yes — fully documented and practiced, Yes — documented but not practiced, Informal process, No formal escalation matrix
• Who must be notified within the first hour of a retail hold or recall (roles/titles)?
• What are your SLA expectations for a co-manufacturer's initial response and containment actions in a severe quality event? Options: Immediate (within 1 hour), Same business day, 24–48 hours, Longer
• Have you run a tabletop recall or escalation exercise in the past 12 months? What worked and what didn't? Options: Yes — successful, Yes — exposed gaps, No — never run one, Not sure
• Would you expect the co-manufacturer to provide owned recall management (press, retailer liaison, logistics)? Options: Yes — full support, Limited support only, No — we handle externally, Depends on contract

Capacity, Scheduling, and Priority — Who Wins the Calendar?

• When demand spikes or slots conflict, how are production priorities currently decided? Options: Internal priority matrix, Largest customer gets priority, First-come, first-served, Manual negotiation each time, Other
• How often has your program been bumped or delayed because the manufacturer prioritized another client in the past year? Options: Frequently (monthly), Occasionally (quarterly), Rarely, Never, Not applicable
• What level of guaranteed capacity would you require to feel comfortable moving forward (cases/month or % of demand)?
• How flexible are your launch windows—do you have hard retail dates or can dates move? Options: Hard retail commitment (no change), Some flexibility (±2 weeks), Flexible (±1–2 months), Flexible/unknown
• Describe how forecasting inaccuracies have affected scheduling and inventory (examples and frequency).
• Would you consider shared capacity guarantees tied to lead times, penalties, or priority tiers? Options: Yes — penalties acceptable, Yes — prefer priority tiers, Maybe — need to discuss, No

If We Had to Ship Tomorrow, What Would Stop This Product?

• What single issue is most likely to derail a launch in the next 90 days? Options: Ingredient shortage, Packaging unavailability, Failed trial batch, Regulatory/label hold, Capacity scheduling conflict, Other
• Which regulatory or retail approvals are outstanding (e.g., label, allergen, nutrition, retailer compliance)?
• Do you have final art and label sign-off? If not, what remains? Options: Finalized and approved, Awaiting legal/regulatory check, Artwork in progress, Not started
• What contingencies do you already have for critical items (alternate suppliers, safety stock, fallback packaging)?
• How would you rate your organization's appetite for short-term compromises (e.g., alternate ingredient, temporary packaging) to meet a go-live? Options: Low — must be exact, Moderate — some substitutions OK, High — pragmatic about compromises, Depends on the change
• If a supplier or label issue emerged, who in your team has the mandate to approve an emergency substitution?

Wrap and Prioritize — What Should We Fix First Together?

• Looking across everything we've discussed, which three issues would you put at the top of the 'fix this now' list?
• Which of these would you like us to take ownership of immediately under an exploratory NDA? Options: Supplier audits & COA review, Run trial batch & sensory validation, Capacity commitment discussion, Label/regulatory review, Escalation matrix co-design, Other
• How comfortable are you sharing formulation details under NDA to shorten technical qualification? Options: Very comfortable, Comfortable with redactions, Prefer to share only after mutual NDA, Not comfortable
• What would success look like 30 days from now if we start working together today?
• Who else should be included in next-step conversations (roles and best contact method)?
• Are you willing to schedule a site tour or virtual line walk to validate constraints and build trust? Options: Yes — in-person tour, Yes — virtual line walk, Maybe — need more info, No

Getting Oriented — Tell Us About This Launch

• What product or SKU are you planning to launch or urgently re-source right now? (Include pack size and flavor/variety)
• Which of these best describes why you’re engaging a co-manufacturer today? Options: New product launch (line extension), Scaling from pilot to full production, Co-manufacturer quality failure / recall, Capacity gap for seasonal peak, Other
• What is your target commercial launch window or go-live date? Options: Within 30 days, 1–3 months, 3–6 months, 6+ months, Date TBD
• Who is on your internal decision team for this project? List titles/roles and one line about their priority (e.g., 'Private Label Manager — speed to shelf').
• What single metric will make you feel this launch was successful? Options: On-time-to-shelf, Zero quality incidents/recalls, First-run taste parity, Profit margin target, Retailer acceptance/slotting, Other
• How much ramp do you expect in the first 6 months (cases per month)? Options: <5k, 5k–20k, 20k–50k, 50k–100k, 100k+

What’s Keeping You Awake About Production?

• If things went wrong on day one of production, what’s the worst-case outcome you secretly worry about? Options: Retailer recall, Failed audit and delisting, Consumer complaints/taste failures, Missed promotional launch, Severe margin erosion, Other
• How often in the past 24 months have you experienced a production or quality disruption that affected your brand? Options: Never, Once, 2–3 times, 4+ times, Not tracked
• Tell us about the most painful disruption you’ve had — what happened, who felt the pressure, and how long did recovery take?
• When disruptions happen, which internal pressures are strongest — speed, cost, reputation, or regulatory exposure? Options: Speed to re-source, Minimize cost impact, Protect retailer relationship/reputation, Meet audit/regulatory obligations, Other
• How does that pressure show up emotionally or politically inside your organization? Options: Executive escalation, Retailer calls, Brand team burnout, Procurement override, Legal involvement, Minimal emotion/managed

Where Your Supply Chain Is Fragile — Let’s Name It

• Tell me: which suppliers or parts of the chain feel like single points of failure today? Options: Single-source ingredient, Proprietary packaging supplier, Single co-manufacturer, Specialty ingredient from one country, Freight/logistics chokepoint, Other
• How long would it take to recover if that single point failed — days, weeks, or months? Be specific. Options: <7 days, 7–30 days, 1–3 months, 3+ months, Unsure
• What contingencies do you already have in place (alternate suppliers, safety stock, specification flex)? Options: Alternate ingredient suppliers, Alternate packaging vendors, Safety stock buffer, Flexible spec allowances, None, Other
• When a supplier slips, who on your team is expected to own the fix, and how does that typically work? Options: Procurement, Supply Chain Director, Brand Manager, Quality/Regulatory, Cross-functional task force, Other
• What’s been the emotional or commercial cost of those slips (lost sales, retailer fines, internal rework)? Provide an example if possible.

When Scale Breaks the Recipe — Tell the Truth

• Have you seen a pilot batch taste or behave differently when scaled? If yes, how did consumers or customers react? Options: Yes — negative reaction, Yes — minor differences but acceptable, No — consistent, Not yet scaled
• Which attributes are most fragile when moving from pilot to line (taste, texture, appearance, fill weight, shelf life)? Options: Taste, Texture/mouthfeel, Appearance/color, Fill/weight accuracy, Packaging fit/seal, Shelf life/stability
• What are your absolute acceptance criteria for a trial batch (sensory scores, lab specs, audit thresholds)? Please list numeric thresholds where applicable.
• Who needs to sign off on a successful trial batch inside your organization (names/roles)?
• If a scale-up shows a persistent deviation, how much variation are you willing to tolerate before pausing a launch? Options: Zero deviation — must match, Small, specified variance, Wide tolerance if cost/time saved, Willing to rework product, Depends on attribute

What ‘On-Shelf Success’ Really Means to You

• If this SKU is on shelf for 3 months and considered a success, what are the top three measurable outcomes you’d point to?
• Which commercial constraints from retailers matter most (slotting timelines, promotional support, EDI integration, labeling)? Options: Slotting lead time, Promotional scheduling, EDI/ordering integration, Labeling/UPC approval, Retailer audit access, Other
• How important is matching or improving the brand’s cost per unit versus maintaining sensory parity? Options: Sensory parity is top priority, Cost parity is top priority, Both equally important, Depends on retailer demands
• What consumer feedback channels will you monitor post-launch and who will own them? Options: Retailer chargebacks, Consumer hotline/social, Third-party QC lab, In-store sensory panels, No formal monitoring
• What commercial penalties or remediation steps would be triggered by a quality issue (refunds, delisting, promotional liability)?

Trade-Offs: What You Can Bend — and What You Can’t

• If you had to prioritize two non-negotiables among these, which would they be: IP protection, audit access, guaranteed capacity, or lead-time certainty? Options: IP protection, Audit access, Guaranteed capacity, Lead-time certainty
• Which commercial flexibility are you willing to trade (price, lead-time, MOQ) to get faster qualification or prioritized capacity? Options: Higher price, Shorter lead-times, Higher MOQ commitment, Preferred payment terms, None
• How sensitive is your brand to sharing formulations or supplier lists with a contract manufacturer? Options: Very sensitive — limited sharing, Somewhat sensitive — NDAs required, Comfortable sharing with controls, No concerns
• What level of audit access do you require (onsite anytime, scheduled audit windows, remote audit only)? Options: Onsite anytime, Scheduled audit windows, Remote audits only, Retailer-led audit access
• If capacity becomes constrained, what escalation or priority mechanism do you expect from a partner? Options: Contracted capacity allocation, Priority for promotional runs, Buy-back/penalty clauses, Transparent waitlist and lead-time updates, Other

Picture Your Ideal Co-Manufacturer — Be Honest

• What three qualities would make you choose a single co-manufacturer over splitting production across vendors?
• How important are low minimum runs (e.g., 5k cases) versus deep scale capability in your decision? Options: Low MOQ most important, Deep scale most important, Both equally important, Depends on SKU lifecycle
• What sample/validation path would build your confidence fastest (single trial batch, sensory panel, joint audit, packaged shelf test)? Options: Single trial batch, Sensory panel, Joint audit verification, Packaged shelf life test, Multi-run validation
• What cadence of communication and reporting would make you feel in control during qualification and launch? Options: Daily updates during trial, Weekly status calls, Biweekly executive summaries, Real-time dashboard access, Ad-hoc as needed
• Which packaging capabilities are deal-breakers for you (vacuum fill, MAP, retort, custom pouches, automated case pack)? Options: Vacuum fill, MAP, Retort, Custom pouches, Automated case pack, None are deal-breakers

Regulatory, Audit, and Labeling — Let’s Get Real

• What certifications or audit levels must any partner demonstrate before you’ll move forward (SQF Level, BRC, third-party audits)? Options: SQF Level 2, SQF Level 3, BRC, Customer-specific audit, Retailer-led audit only, Other
• Are there label or regulatory sign-offs needed from specific teams or regions before production can begin? Options: In-house regulatory team, Retailer labeling approval, Third-party legal review, No special sign-offs
• What allergen, country-of-origin, or ingredient sourcing constraints must we honor?
• How do you prefer sample logistics handled for trials (ship from us, ship-to us, courier with temperature control)? Options: Ship from you to us, We ship to you, Courier with temp control, Local pickup, Other
• If an audit finds a minor non-conformance during qualification, what remediation timeline is acceptable to you? Options: Immediate rectification within days, 1–2 weeks, Up to 30 days, Depends on severity, Would pause launch

Money, Terms, and Mutual Commit — What Would Seal the Deal

• What commercial terms are non-negotiable for you to sign a capacity agreement (lead-time guarantees, minimum buy, penalty clauses)?
• Would you consider capacity guarantees that are tied to committed minimums or to penalty/credit structures? Options: Minimum committed volume, Penalty/credit structure, Combination, Neither/unsure
• How long do you expect contract negotiations to take from initial term sheet to signed agreement? Options: <2 weeks, 2–4 weeks, 1–2 months, 2+ months, Depends on legal review
• Which confidentiality or IP protections do you need in place before sharing formulas or supplier lists? Options: Mutual NDA, IP carve-outs, Controlled access to formula docs, Onsite viewing only, Other
• What billing and payment terms are typical for you (net 30, net 45, milestone-based, deposit + balance)? Options: Net 30, Net 45, Net 60, Deposit + balance, Milestone-based

Decisions, Next Steps, and a Practical Pilot Plan

• Realistically, what is your decision timeline from qualification to awarding production (days/weeks/months)? Options: Within 1 week, 1–3 weeks, 1–2 months, 2–3 months, Undecided
• What would you need from us this week to move to a pilot (sample pack, NDA, draft scope of work, cost estimate)? Options: Sample pack, Mutual NDA, Draft SOW, Cost estimate, Capacity calendar
• Who on your side must approve the pilot and what data will they require to say yes?
• What would be a minimally acceptable pilot success checklist (sensory pass, lab specs, packaging fit, retailer sample approval)?
• If we provided a one-page risk register and a contingency sourcing plan, would that help accelerate your decision? Options: Yes — definitely, Maybe — depends on details, No — not helpful

Tell Us About the Product That Keeps You Up at Night

• What's the SKU name, product type, and pack size for the launch you want us to support?
• Which product category best describes this SKU? Options: Snacks, Baked goods, Sauces, Dressings, Seasonings, Frozen prepared foods, Beverages, Other
• Who is the primary buyer or sales channel for this SKU (pick all that apply)? Options: National grocery private label, Regional grocery, National CPG brand, Foodservice distributor, Foodservice operator/chain, E‑commerce direct-to-consumer, Other
• List the three sensory attributes (taste, texture, appearance, aroma, mouthfeel) that are non‑negotiable for your customers.
• Does this formulation include any allergens, novel ingredients, or proprietary processing steps we should know about? Options: Yes, No
• If yes, briefly describe the ingredient or process and any special handling it requires.

Who Holds the Keys? — Timeline, Decision Makers, and What They Fear

• If this launch goes sideways, whose job metrics or brand reputation is most at risk—and why would they lose sleep?
• Who are the decision-makers we need actively involved from your side (titles and roles)?
• What is your target go‑live date and how fixed is that timeline? Options: Fixed (cannot move), Firm but could slip 1–2 weeks, Flexible within a month, No firm date
• What level of schedule risk are you willing to accept to hit the date (pick one)? Options: No risk — must meet date, Minor risk tolerable, Open to trade-offs on features to meet date, Flexible
• How do your stakeholders define 'launch success'—list measurable outcomes each stakeholder cares about (e.g., first‑order fill rate, sensory pass rate, audit score)?
• Who needs audit or plant‑visit access during qualification and how quickly can they be scheduled? Options: Brand QA lead, Supply chain director, Retailer/Category manager, Third-party auditor, No visits required, Other

What Keeps You Up at Night About Quality and Supply

• When you picture a quality failure for this product, what's the scariest realistic scenario that comes to mind?
• Have you experienced a recall, failed audit, or supplier quality failure in the past 24 months that prompted this search? Options: Yes — recall, Yes — failed audit, Yes — chronic delivery issues, No
• If yes, briefly describe what happened, how it was discovered, and what the escalation path looked like.
• What are your current acceptance thresholds for critical quality measures (microbiology, moisture, % solids, defect rate)? Options: You provide spec, We need guidance, Industry standard tolerances, Other
• How often do you require lot testing or sensory panels during pilot and scale runs? Options: Per trial batch, Weekly during ramp, Monthly, As needed, Other
• Who is your current escalation contact at the co‑manufacturer or supplier, and how long has that arrangement been in place?

Are Your Acceptance Criteria Realistic — Hard Stops vs. Negotiable Items

• Which acceptance criteria are absolute dealbreakers—and which could we systematically test and relax if needed?
• Do you require a minimum SQF or BRC audit score to proceed? If so, what is the minimum and are there specific critical non‑conformances that would stop production? Options: SQF Level 3 required, SQF Level 2 acceptable, BRC required, No minimum specified, Other
• For sensory acceptance, what pass rate do you expect from a trial panel (e.g., 90% match to target)? Options: ≥95%, 90–94%, 80–89%, <80%, No set pass rate
• What statistical or sampling plan do you want for scale validation (e.g., sample size, key analytes)? Options: We have a plan, We need help designing one, Industry standard sampling, Other
• If a trial batch narrowly misses one acceptance metric, what remediation steps are acceptable (rework, parameter tweak, re-run)? Options: Rework acceptable, Parameter adjustments + re-test, Re-run required, Reject batch, Case-by-case

Timing, Scale & The Capacity Rubicon

• What's more likely to derail your launch: ingredient scarcity, packaging availability, or production slot conflicts—and why?
• What is the planned initial order size and the expected 6‑ and 12‑month run rates? Options: <5,000 units initially, 5,000–25,000, 25,000–100,000, >100,000, TBD
• Describe how you anticipate volume ramping over the first year (steady linear growth, step jumps, seasonal spikes). Options: Linear ramp, Step increases, Seasonal peaks, Unpredictable demand, Other
• How much flexibility do you need on minimum order quantities and capacity allocation during peak seasons? Options: No flexibility — strict MOQs, Some flexibility OK, Highly flexible needed, Not sure
• Would you accept a staged rollout (pilot regions or retailers first) to reduce risk to national launch? Options: Yes — staged preferred, Maybe — depends on terms, No — national launch only

Hidden Constraints, Unspoken Rules & Secrets

• What's something about your procurement rules or commercial prefs you can't easily put in an RFP but that would affect whether we can win this business?
• Do you have approved‑vendor lists, exclusive ingredient suppliers, or proprietary packaging partnerships that any co‑manufacturer must use? Options: Yes — strict suppliers, Yes — preferred but flexible, No approved vendor list, Other
• Are there IP protections or NDAs you require before sharing full formulations or process steps? Options: Standard NDA, Mutual NDA + IP addendum, Full proprietary license required, No special NDA
• Do you have labeling, regulatory, or country‑specific compliance constraints that could delay production (claims, nutrition, language requirements)? Options: US labeling only, Multi‑country labeling, Regulatory reviews pending, Other
• How do you prefer samples to be handled for sensory and audit review (ship to you, third‑party lab, retailer)? Options: Ship to brand, Third‑party lab, Ship to retailer, Other

If Everything Worked Perfectly — What Would Change?

• If you could guarantee one outcome from a new co‑manufacturing partner, which single result would change your strategy the most (zero recalls, perfect taste repeatability, guaranteed capacity, price stability)? Options: Zero recalls, Perfect sensory repeatability, Guaranteed capacity, Lower COGS, Faster time-to-shelf, Other
• What KPIs will you use to judge our partnership in the first 90 and 180 days?
• How important is ongoing continuous improvement (e.g., quarterly trials, yield improvements, waste reduction) after launch? Options: Critical, Important, Nice to have, Not a priority
• Would you want a shared ticketing channel or dedicated escalation pathway for post‑launch issues? Options: Shared ticketing channel, Dedicated escalation contact, Both, Neither
• What reporting cadence and level of transparency would put you most at ease during ramp (daily production updates, weekly quality reports, monthly business reviews)? Options: Daily updates, Weekly reports, Monthly reviews, Ad-hoc as needed

Decisions, Trade‑offs & Clear Next Steps

• What is the single compromise you are willing to make today to avoid a three‑month delay? Options: Change packaging, Adjust initial volume, Accept longer lead time, Flexible sensory tolerance, Other
• What commercial or contractual protections do you require to move forward (capacity guarantees, audit access, escape clauses, penalties)? Options: Capacity guarantees, Audit access, Confidentiality/IP clauses, Acceptance/escape clauses, Penalties for non-performance, Other
• How quickly can you make a sourcing decision once pilot results and audit verifications are complete? Options: Immediately, Within 1–2 weeks, Within a month, Longer — requires internal approvals
• Would you like us to propose a pilot plan that includes timelines, acceptance gates, and contingency sourcing options? Options: Yes — please propose, Maybe — need internal alignment first, No — we’ll request a plan later
• Who should be on the next call to finalize pilot scope and priorities (names and roles)?